Herlapsa Tablet
By Herlapsa
Rx
30 Tablet in a Bottle

Composition
Lapatinib(250mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
September, 2025

liver
Caution should be taken when using Herlapsa Tablet in individuals with liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is advised to consult with your doctor before using Herlapsa Tablet, especially for patients with severe liver disease as there is limited information available on its use in this particular condition.

kidney
Caution should be taken when using Herlapsa Tablet in patients with severe kidney disease as dose adjustment may be necessary. Consult your doctor as limited information is available for this group. No dose adjustment is needed for patients with mild to moderate kidney disease.

alcohol
Consult your doctor when consuming alcohol with Herlapsa Tablet.

driving
When taking Herlapsa Tablet, be cautious while driving, as it may cause side effects that can impact your driving ability.

pregnancy
Herlapsa Tablet is not safe for use during pregnancy due to potential risk to the developing baby. Consult your doctor before use, as they may only prescribe it in life-threatening situations if benefits outweigh risks.

breastfeeding
Caution should be taken during breastfeeding, as Herlapsa Tablet is considered unsafe due to potential toxicity to the baby. It is better to consult your doctor before using Herlapsa Tablet.
Habit Forming | No |
Chemical Class | Quinazolinamines Derivative |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Tyrosine kinase inhibitors |
₹8057
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024